The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.
Precision medicine
antiphospholipid syndrome
primary Sjogren’s syndrome
rheumatoid arthritis
spondyloarthritides
systemic lupus erythematosus
systemic sclerosis
Journal
Autoimmunity reviews
ISSN: 1873-0183
Titre abrégé: Autoimmun Rev
Pays: Netherlands
ID NLM: 101128967
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
13
09
2020
accepted:
22
09
2020
pubmed:
17
12
2020
medline:
16
2
2021
entrez:
16
12
2020
Statut:
ppublish
Résumé
Autoimmune diseases (AIDs) share similar serological, clinical, and radiological findings, but, behind these common features, there are different pathogenic mechanisms, immune cells dysfunctions, and targeted organs. In this context, multiple lines of evidence suggest the application of precision medicine principles to AIDs to reduce the treatment failure. Precision medicine refers to the tailoring of therapeutic strategies to the individual characteristics of each patient, thus it could be a new approach for management of AIDS which considers individual variability in genes, environmental exposure, and lifestyle. Precision medicine would also assist physicians in choosing the right treatment, the best timing of administration, consequently trying to maximize drug efficacy, and, possibly, reducing adverse events. In this work, the growing body of evidence is summarized regarding the predictive factors for drug response in patients with AIDs, applying the precision medicine principles to provide high-quality evidence for therapeutic opportunities in improving the management of these patients.
Identifiants
pubmed: 33326854
pii: S1568-9972(20)30319-0
doi: 10.1016/j.autrev.2020.102738
pii:
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102738Subventions
Organisme : Versus Arthritis
ID : 21268
Pays : United Kingdom
Organisme : Department of Health
ID : 11/100/76
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K015346/1
Pays : United Kingdom
Organisme : Department of Health
ID : TRF-2018-11-ST2-002
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003063/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800648
Pays : United Kingdom
Informations de copyright
Copyright © 2020. Published by Elsevier B.V.